Cargando…

A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor

[Image: see text] The yeast Saccharomyces cerevisiae is commonly used to interrogate and screen protein variants and to perform directed evolution studies to develop proteins with enhanced features. While several techniques have been described that help enable the use of yeast for directed evolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazier, Andrew P., Irvin, Olivia M., Chávez, Lizmarie S., Dalvi, Saachi, Abraham, Hannah, Wickramanayake, Nevinka, Yellayi, Sreenivas, Blazeck, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661033/
https://www.ncbi.nlm.nih.gov/pubmed/37873982
http://dx.doi.org/10.1021/acssynbio.3c00299
_version_ 1785148449137623040
author Cazier, Andrew P.
Irvin, Olivia M.
Chávez, Lizmarie S.
Dalvi, Saachi
Abraham, Hannah
Wickramanayake, Nevinka
Yellayi, Sreenivas
Blazeck, John
author_facet Cazier, Andrew P.
Irvin, Olivia M.
Chávez, Lizmarie S.
Dalvi, Saachi
Abraham, Hannah
Wickramanayake, Nevinka
Yellayi, Sreenivas
Blazeck, John
author_sort Cazier, Andrew P.
collection PubMed
description [Image: see text] The yeast Saccharomyces cerevisiae is commonly used to interrogate and screen protein variants and to perform directed evolution studies to develop proteins with enhanced features. While several techniques have been described that help enable the use of yeast for directed evolution, there remains a need to increase their speed and ease of use. Here we present yDBE, a yeast diversifying base editor that functions in vivo and employs a CRISPR-dCas9-directed cytidine deaminase base editor to diversify DNA in a targeted, rapid, and high-breadth manner. To develop yDBE, we enhanced the mutation rate of an initial base editor by employing improved deaminase variants and characterizing several scaffolded guide constructs. We then demonstrate the ability of the yDBE platform to improve the affinity of a displayed antibody scFv, rapidly generating diversified libraries and isolating improved binders via cell sorting. By performing high-throughput sequencing analysis of the high-activity yDBE, we show that it enables a mutation rate of 2.13 × 10(–4) substitutions/bp/generation over a window of 100 bp. As yDBE functions entirely in vivo and can be easily programmed to diversify nearly any such window of DNA, we posit that it can be a powerful tool for facilitating a variety of directed evolution experiments.
format Online
Article
Text
id pubmed-10661033
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-106610332023-11-21 A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor Cazier, Andrew P. Irvin, Olivia M. Chávez, Lizmarie S. Dalvi, Saachi Abraham, Hannah Wickramanayake, Nevinka Yellayi, Sreenivas Blazeck, John ACS Synth Biol [Image: see text] The yeast Saccharomyces cerevisiae is commonly used to interrogate and screen protein variants and to perform directed evolution studies to develop proteins with enhanced features. While several techniques have been described that help enable the use of yeast for directed evolution, there remains a need to increase their speed and ease of use. Here we present yDBE, a yeast diversifying base editor that functions in vivo and employs a CRISPR-dCas9-directed cytidine deaminase base editor to diversify DNA in a targeted, rapid, and high-breadth manner. To develop yDBE, we enhanced the mutation rate of an initial base editor by employing improved deaminase variants and characterizing several scaffolded guide constructs. We then demonstrate the ability of the yDBE platform to improve the affinity of a displayed antibody scFv, rapidly generating diversified libraries and isolating improved binders via cell sorting. By performing high-throughput sequencing analysis of the high-activity yDBE, we show that it enables a mutation rate of 2.13 × 10(–4) substitutions/bp/generation over a window of 100 bp. As yDBE functions entirely in vivo and can be easily programmed to diversify nearly any such window of DNA, we posit that it can be a powerful tool for facilitating a variety of directed evolution experiments. American Chemical Society 2023-10-24 /pmc/articles/PMC10661033/ /pubmed/37873982 http://dx.doi.org/10.1021/acssynbio.3c00299 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Cazier, Andrew P.
Irvin, Olivia M.
Chávez, Lizmarie S.
Dalvi, Saachi
Abraham, Hannah
Wickramanayake, Nevinka
Yellayi, Sreenivas
Blazeck, John
A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor
title A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor
title_full A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor
title_fullStr A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor
title_full_unstemmed A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor
title_short A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor
title_sort rapid antibody enhancement platform in saccharomyces cerevisiae using an improved, diversifying crispr base editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661033/
https://www.ncbi.nlm.nih.gov/pubmed/37873982
http://dx.doi.org/10.1021/acssynbio.3c00299
work_keys_str_mv AT cazierandrewp arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT irvinoliviam arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT chavezlizmaries arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT dalvisaachi arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT abrahamhannah arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT wickramanayakenevinka arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT yellayisreenivas arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT blazeckjohn arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT cazierandrewp rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT irvinoliviam rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT chavezlizmaries rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT dalvisaachi rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT abrahamhannah rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT wickramanayakenevinka rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT yellayisreenivas rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor
AT blazeckjohn rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor